Skip to main content
All lobbying filings

CORNERSTONE GOVERNMENT AFFAIRS, INC.

Lobbying for OCTAPHARMA USA, INC. · Pharmaceuticals

 Filing Registration
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 8, 2025
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
New Jersey

Official filing document

 Lobbyists on this filing 6
  • RONALD STORHAUG New on this filing
    Previously held: Dep Asst Sec, Dep of Treasury; Director of Tax and Econ Policy, TaxandEconPolicy Advisor, Senate Small Business Cmte; Sr Econ PolicyAdvisor,EconPolicy Advisor, Legis Asst, Senate MemberOffice(Kaine);Staff Asst,SenateBudget Committee
  • DABNEY HEGG New on this filing
    Previously held: Clerk, Sen Approps Cmte; Prof Staff, Sen Approps Cmte; Sr ProfStaff, SenateCmte on Commerce, Science, and Transportation; Prof Staff, SenateCmte onCommerce, Science, and Transportation; LegAsst(Hollings); StaffAsst(Hollings); Intern(Hollings)
  • CHRISTOPHER HODGSON New on this filing
    Previously held: Legislative Assistant (Scalise), Floor Assistant & Deputy Floor Director for House Majority Whip (Scalise), Deputy Director & Director of Legislative Affairs (Pence)
  • ANTHONY LAZARSKI New on this filing
    Previously held: Senior Legislative Advisor, Senate Member Office (Inhofe); Professional Staff Member, Senate Armed Services Committee; Military Legislative Assistant, Senate Member Office (Inhofe)
  • SUSAN SWEAT New on this filing
    Previously held: LC, LA & LD House Office (Wicker); LD Senate Member Office (Wicker)
  • WENDY SAMMONS-JACKSON New on this filing
    Previously held: Director, Military Infectious Diseases Research Program, US Army Medical Research and Development Command

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 3

Educate key stakeholders across the federal government on Octapharmas capabilities in support of National Security and supply chain resilience.

Educate key stakeholders across the federal government on Octapharmas capabilities in support of National Security and supply chain resilience.

Educate key stakeholders across the federal government on Octapharmas capabilities in support of National Security and supply chain resilience.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem